Cancer epigenetics: above and beyond
暂无分享,去创建一个
[1] Dustin E. Schones,et al. Dynamic Regulation of Nucleosome Positioning in the Human Genome , 2008, Cell.
[2] Hong Peng,et al. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. , 2010, Lung cancer.
[3] Peter A. Jones,et al. Cellular differentiation, cytidine analogs and DNA methylation , 1980, Cell.
[4] R C Coombes,et al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] Cizhong Jiang,et al. Nucleosome positioning and gene regulation: advances through genomics , 2009, Nature Reviews Genetics.
[6] R. Feil,et al. Chromatin mechanisms in genomic imprinting , 2009, Mammalian Genome.
[7] Y. Yatabe,et al. Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.
[8] Gangning Liang,et al. Preferential response of cancer cells to zebularine. , 2004, Cancer cell.
[9] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[10] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[11] L. Lim,et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.
[12] P. Laird. Cancer epigenetics. , 2005, Human molecular genetics.
[13] Peter A. Jones,et al. Hypomethylation of a LINE-1 Promoter Activates an Alternate Transcript of the MET Oncogene in Bladders with Cancer , 2010, PLoS genetics.
[14] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[15] S. Ropero,et al. A microRNA DNA methylation signature for human cancer metastasis , 2008, Proceedings of the National Academy of Sciences.
[16] A. Partin,et al. p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape , 2008, The Prostate.
[17] S. Henikoff,et al. Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription , 2007, Nature Genetics.
[18] Ruian Xu,et al. Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. , 2009, Current cancer drug targets.
[19] Ping Zhu,et al. Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. , 2004, Cancer cell.
[20] Illinois.,et al. Cancer Genetics , 1976, British Journal of Cancer.
[21] Robert S. Illingworth,et al. CpG islands influence chromatin structure via the CpG-binding protein Cfp1 , 2010, Nature.
[22] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[23] S. Minucci,et al. Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor , 2002, Science.
[24] S. C. Lakhotia,et al. What is a gene? , 1997 .
[25] David I. K. Martin,et al. Epigenetic inheritance at the agouti locus in the mouse , 1999, Nature Genetics.
[26] K. Kelnar,et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. , 2011, Nature medicine.
[27] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[28] Paul Cairns,et al. Gene methylation and early detection of genitourinary cancer: the road ahead , 2007, Nature Reviews Cancer.
[29] M. Esteller. Epigenetic gene silencing in cancer: the DNA hypermethylome. , 2007, Human molecular genetics.
[30] G. Riddihough,et al. What Is Epigenetics , 2010 .
[31] M. Surani,et al. Epigenetic reprogramming in mouse primordial germ cells , 2002, Mechanisms of Development.
[32] Manel Esteller,et al. How epigenetics integrates nuclear functions , 2005 .
[33] A. Bird,et al. Genomic DNA methylation: the mark and its mediators. , 2006, Trends in biochemical sciences.
[34] B. Weissman,et al. Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer. , 2009, Cancer research.
[35] W. Reik,et al. Epigenetic Reprogramming in Mammalian Development , 2001, Science.
[36] Fabricio F Costa,et al. Cancer Management and Research Dovepress Epigenomics in Cancer Management , 2022 .
[37] David Sidransky,et al. MicroRNA alterations in head and neck squamous cell carcinoma , 2008, International journal of cancer.
[38] Reuven Agami,et al. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. , 2007, The EMBO journal.
[39] R. Weinberg,et al. Micromanagers of malignancy: role of microRNAs in regulating metastasis. , 2008, Trends in genetics : TIG.
[40] M. Surani,et al. Genomic imprinting and cancer. , 1995, Cancer surveys.
[41] Kelly M. McGarvey,et al. The cancer epigenome--components and functional correlates. , 2006, Genes & development.
[42] L. Looijenga,et al. Testicular germ-cell tumours in a broader perspective , 2005, Nature Reviews Cancer.
[43] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[44] Steven S. Chang,et al. Integrative Discovery of Epigenetically Derepressed Cancer Testis Antigens in NSCLC , 2009, PloS one.
[45] David Sidransky,et al. Emerging molecular markers of cancer , 2002, Nature Reviews Cancer.
[46] S. Minucci,et al. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer , 2006, Nature Reviews Cancer.
[47] Y. Yatabe,et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. , 2005, Cancer research.
[48] S. Minucci,et al. MBD3, a Component of the NuRD Complex, Facilitates Chromatin Alteration and Deposition of Epigenetic Marks , 2008, Molecular and Cellular Biology.
[49] Qiang Yu,et al. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. , 2007, Genes & development.
[50] A. Lal,et al. MicroRNAs and their target gene networks in breast cancer , 2010, Breast Cancer Research.
[51] C. Croce,et al. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. , 2007, Endocrine-related cancer.
[52] A. Sparreboom,et al. Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review , 2005, Molecular Pharmacology.
[53] J. Issa. CpG island methylator phenotype in cancer , 2004, Nature Reviews Cancer.
[54] F. Costa,et al. Non‐coding RNAs: Meet thy masters , 2010, BioEssays : news and reviews in molecular, cellular and developmental biology.
[55] J. Jost,et al. The formation of DNA methylation patterns and the silencing of genes. , 1997, Progress in nucleic acid research and molecular biology.
[56] Z. Herceg,et al. Epigenetic drivers and genetic passengers on the road to cancer. , 2008, Mutation research.
[57] H. Sültmann,et al. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. , 2007, Cancer research.
[58] Hengbin Wang,et al. Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing , 2002, Science.
[59] S. Zukin,et al. Epigenetics , 2009, Alzheimer's & Dementia.
[60] M. Esteller,et al. Proteins that bind methylated DNA and human cancer: reading the wrong words , 2008, British Journal of Cancer.
[61] T. Richmond,et al. Crystal structure of the nucleosome core particle at 2.8 Å resolution , 1997, Nature.
[62] L. Aaltonen,et al. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition , 2006, Nature Genetics.
[63] D. Pisano,et al. Mechanistic principles of chromatin remodeling guided by siRNAs and miRNAs , 2008, Cell cycle.
[64] M. Ehrlich. DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements. , 2002, Journal of NutriLife.
[65] E. Schuuring,et al. Genome-wide promoter analysis uncovers portions of the cancer methylome. , 2008, Cancer research.
[66] Daiya Takai,et al. Comprehensive analysis of CpG islands in human chromosomes 21 and 22 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[67] P. V. van Helden,et al. Hypomethylation of DNA in pathological conditions of the human prostate. , 1987, Cancer research.
[68] Peter A. Jones,et al. Cancer epigenetics: modifications, screening, and therapy. , 2008, Annual review of medicine.
[69] Adrian Bird,et al. The essentials of DNA methylation , 1992, Cell.
[70] Peter A. Jones,et al. Cancer-epigenetics comes of age , 1999, Nature Genetics.
[71] M. Caligiuri,et al. Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.
[72] S. Baylin,et al. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.
[73] Carla Oliveira,et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function , 2009, Nature Genetics.
[74] F. Costa,et al. The impact of microRNAs and alternative splicing in pharmacogenomics , 2009, The Pharmacogenomics Journal.
[75] A. Riggs,et al. 5-methylcytosine, gene regulation, and cancer. , 1983, Advances in cancer research.
[76] J. Hicks,et al. Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors , 2008, Modern Pathology.
[77] J. Herman,et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.
[78] Jingde Zhu,et al. Use of DNA methylation for cancer detection: promises and challenges. , 2009, The international journal of biochemistry & cell biology.
[79] C. Allis,et al. Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers , 2010, Nature Reviews Cancer.
[80] Arthur D. Riggs,et al. X inactivation, differentiation, and DNA methylation. , 1975, Cytogenetics and cell genetics.
[81] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[82] Rachel Jones,et al. Behavioural genetics: Worms gang up on bacteria , 2002, Nature Reviews Genetics.
[83] Israel Steinfeld,et al. Developmental programming of CpG island methylation profiles in the human genome , 2009, Nature Structural &Molecular Biology.
[84] Manoj Bhasin,et al. Recognition and Classification of Histones Using Support Vector Machine , 2006, J. Comput. Biol..
[85] Hsien-Da Huang,et al. MicroRNA‐122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma , 2009, Hepatology.
[86] R. Agami,et al. Tumorigenicity of the miR-17-92 cluster distilled. , 2010, Genes & development.
[87] Steven S. Chang,et al. Coordinated Activation of Candidate Proto-Oncogenes and Cancer Testes Antigens via Promoter Demethylation in Head and Neck Cancer and Lung Cancer , 2009, PloS one.
[88] D. Bartel,et al. The impact of microRNAs on protein output , 2008, Nature.
[89] M. Hoque,et al. Epigenomics and ovarian carcinoma. , 2010, Biomarkers in medicine.
[90] A. Feinberg,et al. Relaxation of imprinted genes in human cancer , 1993, Nature.
[91] G. Längst,et al. Nucleosome remodeling: one mechanism, many phenomena? , 2004, Biochimica et biophysica acta.
[92] Cyrus Martin,et al. The diverse functions of histone lysine methylation , 2005, Nature Reviews Molecular Cell Biology.
[93] A. Chess,et al. Gene Body-Specific Methylation on the Active X Chromosome , 2007, Science.
[94] M. Esteller,et al. Epigenetic modifications and human disease , 2010, Nature Biotechnology.
[95] D. Ghosh,et al. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. , 2007, Cancer research.
[96] Dieter Jocham,et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. , 2010, Urologic oncology.
[97] Yong Wang,et al. An evaluation of new criteria for CpG islands in the human genome as gene markers , 2004, Bioinform..
[98] C. Croce,et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[99] P. Laird,et al. Hypomethylation and hypermethylation of DNA in Wilms tumors , 2002, Oncogene.
[100] Reuven Agami,et al. Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation , 2007 .
[101] A. Feinberg,et al. Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.
[102] T. Bestor,et al. Formation of methylation patterns in the mammalian genome. , 1997, Mutation research.
[103] S. Baylin,et al. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes , 2007, Proceedings of the National Academy of Sciences.
[104] P. Georgel,et al. Linker histone function in chromatin: dual mechanisms of action. , 2001, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[105] J. Califano,et al. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage , 2007, International journal of cancer.
[106] J. Herman,et al. A gene hypermethylation profile of human cancer. , 2001, Cancer research.
[107] J. Herman,et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.
[108] Colin A. Johnson,et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.
[109] Irene K. Moore,et al. A genomic code for nucleosome positioning , 2006, Nature.
[110] Lani F. Wu,et al. Genome-Scale Identification of Nucleosome Positions in S. cerevisiae , 2005, Science.
[111] Ricky W. Johnstone,et al. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer , 2002, Nature Reviews Drug Discovery.
[112] Sun-Mi Park,et al. The role of let-7 in cell differentiation and cancer. , 2010, Endocrine-related cancer.
[113] J. Issa,et al. DNA Methylation as a Therapeutic Target in Cancer , 2007, Clinical Cancer Research.
[114] Carolyn J. Brown,et al. Epigenetics of cancer progression. , 2008, Pharmacogenomics.
[115] 司履生. Cancer epigenetics , 2006 .
[116] J. Issa. DNA methylation as a therapeutic target in cancer. , 2008, Clinical cancer research : an official journal of the American Association for Cancer Research.
[117] M. Hoque. DNA methylation changes in prostate cancer: current developments and future clinical implementation , 2009, Expert review of molecular diagnostics.
[118] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[119] B. Czerniak,et al. Aberrant Promoter Methylation of Multiple Genes during Pathogenesis of Bladder Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.
[120] Bryan J Venters,et al. A barrier nucleosome model for statistical positioning of nucleosomes throughout the yeast genome. , 2008, Genome research.
[121] B. Cairns,et al. The biology of chromatin remodeling complexes. , 2009, Annual review of biochemistry.
[122] J. Herman,et al. Specific Inhibition of DNMT1 by Antisense Oligonucleotides Induces Re-expression of Estrogen Receptor a (ER) in ER-negative Human Breast Cancer Cell Lines , 2003, Cancer biology & therapy.
[123] T. Spector,et al. Epigenetic differences arise during the lifetime of monozygotic twins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[124] Peter A. Jones,et al. Epigenetics in cancer. , 2010, Carcinogenesis.
[125] C. Scrideli,et al. Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas , 2008, BMC Cancer.
[126] Chang-Zheng Chen,et al. MicroRNAs as oncogenes and tumor suppressors. , 2005, The New England journal of medicine.
[127] T. Kouzarides. Chromatin Modifications and Their Function , 2007, Cell.
[128] J. Licht,et al. Deregulation of H3K27 methylation in cancer , 2010, Nature Genetics.
[129] M. Surani,et al. Cancer genetics. Genomic imprinting and embryonal tumours. , 1989, Nature.
[130] J. Herman,et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. , 2000, Cancer research.
[131] K. Struhl. Histone acetylation and transcriptional regulatory mechanisms. , 1998, Genes & development.
[132] Anna M. Krichevsky,et al. miR-21: a small multi-faceted RNA , 2008, Journal of cellular and molecular medicine.
[133] Debashis Ghosh,et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[134] Peter A. Jones,et al. The Epigenomics of Cancer , 2007, Cell.
[135] Y. Fujii,et al. Regulation of human immunodeficiency virus 1 transcription by nef microRNA. , 2005, The Journal of general virology.
[136] A. M. Salazar,et al. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[137] R. Bast,et al. The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade , 2010, Cancer Microenvironment.
[138] T. Wurdinger,et al. Molecular therapy in the microRNA era , 2007, The Pharmacogenomics Journal.
[139] Andrea Ventura,et al. MicroRNAs and Cancer: Short RNAs Go a Long Way , 2009, Cell.
[140] W. Filipowicz,et al. Inhibition of Translational Initiation by Let-7 MicroRNA in Human Cells , 2005, Science.
[141] J. Yoshida,et al. Epigenetic aberrations and therapeutic implications in gliomas , 2010, Cancer science.
[142] E. Eisenhauer,et al. DNA methyltransferase inhibitors-state of the art. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[143] Lloyd J. Old,et al. Cancer/testis antigens, gametogenesis and cancer , 2005, Nature Reviews Cancer.
[144] Yue-hua Ma,et al. New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer , 2009, Journal of hematology & oncology.
[145] David Sidransky,et al. DNA methylation markers in colorectal cancer , 2010, Cancer and Metastasis Reviews.
[146] M. Surani,et al. Genomic imprinting and embryonal tumours , 1989, Nature.
[147] Cizhong Jiang,et al. A compiled and systematic reference map of nucleosome positions across the Saccharomyces cerevisiae genome , 2009, Genome Biology.
[148] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[149] Helmut Gernsheim,et al. W. H. Fox Talbot and the history of photography , 1977 .
[150] J. Herman,et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.